Mass Spectrometry Imaging Reveals Neutrophil Defensins as Additional Biomarkers for Anti-PD-(L)1 Immunotherapy Response in NSCLC Patients

(1) Background: Therapeutic blocking of the interaction between programmed death-1 (PD-1) with its ligand PD-L1, an immune checkpoint, is a promising approach to restore the antitumor immune response. Improved clinical outcomes have been shown in different human cancers, including non-small cell lun...

Descripción completa

Detalles Bibliográficos
Autores principales: Berghmans, Eline, Jacobs, Julie, Deben, Christophe, Hermans, Christophe, Broeckx, Glenn, Smits, Evelien, Maes, Evelyne, Raskin, Jo, Pauwels, Patrick, Baggerman, Geert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225984/
https://www.ncbi.nlm.nih.gov/pubmed/32252405
http://dx.doi.org/10.3390/cancers12040863

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225984/
https://www.ncbi.nlm.nih.gov/pubmed/32252405
http://dx.doi.org/10.3390/cancers12040863

Ejemplares similares